|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
von Wichert G, Seufferlein T and Adler G:
Palliative treatment of pancreatic cancer. J Dig Dis. 9:1–7. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Le Pimpec Barthes F, Chapuis O, Riquet M,
Cuttat JF, Peillon C, Mouroux J and Jancovici R: Thoracoscopic
splanchnicectomy for control of intractable pain in pancreatic
cancer. Ann Thorac Surg. 65:810–813. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Isla AM, Worthington T, Kakkar AK and
Williamson RC: A continuing role for surgical bypass in the
palliative treatment of pancreatic carcinoma. Dig Surg. 17:143–146.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Handley WS: Pancreatic cancer and the
treatment by implanted radium. Ann Surg. 100:215–222. 1934.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hilaris B and Rousiss K: Cancer of the
pancreasHilaris BS: Handbook of interstitial brachytherapy. Acton,
Mass: Publishing Sciences Group (PSG); pp. 251–262. 1975
|
|
7
|
Syed AM, Puthawala AA and Neblett DL:
Interstitial iodine-125 implant in the management of unresectable
pancreatic carcinoma. Cancer. 52:808–813. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J, Jiang Y, Li J, Tian S, Ran W and
Xiu D: Intraoperative ultrasound-guided iodine-125 seed
implantation for unresectable pancreatic carcinoma. J Exp Clin
Cancer Res. 28:882009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Whittington R, Solin L, Mohiuddin M,
Cantor RI, Rosato FE, Biermann WA, Weiss SM and Pajak TF:
Multimodality therapy of localized unresectable pancreatic
adenocarcinoma. Cancer. 54:1991–1998. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhongmin W, Yu L, Fenju L, Kemin C and
Gang H: Clinical efficacy of CT-guided iodine-125 seed implantation
therapy in patients with advanced pancreatic cancer. Eur Radiol.
20:1786–1791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Wang J, Jiang Y, Li J, Tian S, Ran
W, Xiu D and Gao Y: The investigation of 125I seed implantation as
a salvage modality for unresectable pancreatic carcinoma. J Exp
Clin Cancer Res. 32:1062013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yates JW, Chalmer B and Mckegney FP:
Evaluation of patients with advanced cancer using the karnofsky
performance status. Cancer. 45:2220–2224. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verslype C, Van Cutsem E, Dicato M,
Cascinu S, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D,
Haustermans K, Heinemann V, et al: The management of pancreatic
cancer. Current expert opinion and recommendations derived from the
8th World congress on gastrointestinal cancer, Barcelona, 2006. Ann
Oncol. 18 Suppl 7:vii1–vii10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Banks PA, Bollen TL, Dervenis C, Gooszen
HG, Johnson CD, Sarr MG, Tsiotos GG and Vege SS: Acute Pancreatitis
Classification Working Group: Classification of acute
pancreatitis-2012: Revision of the Atlanta classification and
definitions by international consensus. Gut. 62:102–111. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bassi C, Dervenis C, Butturini G,
Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W
and Buchler M; International Study Group on Pancreatic Fistula
Definition, : Postoperative pancreatic fistula: An international
study group (ISGPF) definition. Surgery. 138:8–13. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murakami Y, Uemura K, Hayashidani Y, Sudo
T, Hashimoto Y, Nakagawa N, Ohge H and Sueda T: No mortality after
150 consecutive pancreatoduodenctomies with duct-to-mucosa
pancreaticogastrostomy. J Surg Oncol. 97:205–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park YC, Kim SW, Jang JY, Ahn YJ and Park
YH: Factors influencing delayed gastric emptying after
pylorus-preserving pancreatoduodenectomy. J Am Coll Surg.
196:859–865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bodner WR and Hilaris BS: Brachytherapy
and pancreatic cancer. Semin Surg Oncol. 13:204–207. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Monk BJ, Tewari KS, Puthawala AA, Syed Am,
Haugen JA and Burger RA: Treatment of recurrent gynecologic
malignancies with iodine-125 permanent interstitial irradiation.
Int J Radiat Oncol Biol Phys. 52:806–815. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dobelbower RR Jr, Merrick HW III, Ahuja RK
and Skeel RT: 125I interstitial implant, precision high-dose
external beam therapy, and 5-FU for unresectable adenocarcinoma of
pancreas and extrahepatic biliary tree. Cancer. 58:2185–2195. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miller AB, Hoogstraten B, Staquet M and
Winkler A: Reporting results of cancer treatment. Cancer.
47:207–214. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aaronson NK, Ahmedzai S, Bergman B,
Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman
SB, de Haes JC, et al: The European Organization for Research and
Treatment of Cancer QLQ-C30: A quality-of-life instrument for use
in international clinical trials in oncology. J Natl Cancer Inst.
85:365–376. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao H and Kanda K: Testing psychometric
properties of the standard Chinese version of the European
Organization for Research and Treatment of Cancer Quality of Life
Core Questionnaire 30 (EORTC QLQ-C30). J Epidemiol. 14:193–203.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Van Heek NT, De Castro SM, van Eijck CH,
van Geenen RC, Hesselink EJ, Breslau PJ, Tran TC, Kazemier G,
Visser MR, Busch OR, et al: The need for a prophylactic
gastrojejunostomy for unresectable periampullary cancer: A
prospective randomizedmulticenter trial with special focus on
assessment of quality of life. Ann Surg. 238:894–905. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bloechle C, Izbicki JR, Knoefel WT,
Kuechler T and Broelsch CE: Quality of life in chronic
pancreatitis: Results after duodenum-preserving resection of the
head of the pancreas. Pancreas. 11:77–85. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma JX, Jin ZD, Si PR, Liu Y, Lu Z, Wu HY,
Pan X, Wang LW, Gong YF, Gao J and Zhao-shen L: Continuous and
low-energy 125I seed irradiation changes DNA methyltransferases
expression patterns and inhibits pancreatic cancer tumor growth. J
Exp Clin Cancer Res. 30:352011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou YP, Li WM, Zheng F, Li FC, Huang H, Du
JD and Liu HR: Intraoperative radiofrequency ablation combined with
125 iodine seed implantation for unresectable pancreatic cancer.
World J Gastroenterol. 16:5104–5110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin Z, Du Y, Li Z, Jiang Y, Chen J and Liu
Y: Endoscopic ultrasonography-guided interstitial implantation of
iodine 125-seeds combined with chemotherapy in the treatment of
unresectable pancreatic carcinoma: a prospective pilot study.
Endoscopy. 40:314–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Freelove R and Walling AD: Pancreatic
cancer: Diagnosis and management. Am Fam Physician. 73:485–492.
2006.PubMed/NCBI
|
|
30
|
Du Y, Jin Z, Meng H, Zou D, Chen J, Liu Y,
Zhan X, Wang D, Liao Z and Li Z: Long-term effect of
gemcitabine-combined endoscopic ultrasonography-guided
brachytherapy in pancreatic cancer. J Interv Gastroenterol.
3:18–24. 2013. View
Article : Google Scholar
|
|
31
|
Kostro J and Sledziński Z: Quality of life
after surgical treatment of pancreatic cancer. Acta Chir Belg.
108:679–684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ueda J, Kayashima T, Mori Y, Ohtsuka T,
Takahata S, Nakamura M and Tanaka M: Hepaticocholecystojejunostomy
as effective palliative biliary bypass for unresectable pancreatic
cancer. Hepatogastroenterology. 61:197–202. 2014.PubMed/NCBI
|
|
33
|
Lillemoe KD, Cameron JL, Hardacre JM, Sohn
TA, Sauter PK, Coleman J, Pitt HA and Yeo CJ: Is prophylactic
gastrojejunostomy indicated for unresectable periampullary
carcinoma? A prospective randomized trial. Ann Surg. 230:322–330.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mann CD, Thomasset SC, Johnson NA, Garcea
G, Neal CP, Dennison AR and Berry DP: Combined biliary and gastric
bypass procedures as effective palliation for unresectable
malignant disease. ANZ J Surg. 79:471–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
